Skip to content

Effect of a reminder system on medication adherence

Effect of a reminder system using a web based short message service on medication adherence in patients with acute coronary syndrome following coronary angioplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016081125937N2
Enrollment
116
Registered
2016-08-29
Start date
2016-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease. Other forms of chronic ischaemic heart disease

Interventions

Intervention 1: Intervention group: Reminder messages will be sent based on medication regimen recommended by physician and based on drug name and dose, in specified intervals for six months. Interven
Intervention group: Reminder messages will be sent based on medication regimen recommended by physician and based on drug name and dose, in specified intervals for six months.
Control group: routine follow up will be done for control group.

Sponsors

Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients aged between 18 and 65 years old hospitalized in Shahid Madani hospital suffering from acute coronary syndrome undergoing percutaneous coronary intervention with drug-eluting stent implantation who has been diagnosed with no significant systolic dysfunction by a cardiologist (without clinical symptoms and ejection fraction greater than 40%); Have the ability to read the contents of the sent text message; participation in the study based on personal desire; Having the access to cell phone and have the ability to use it; Not participated in research projects similar to the current study. Exclusion criteria: Unwillingness to participate in the study; No access to mobile phone; Referring to other treatment centers during the study; inaccessibility to patient after 6 months (ie travel abroad); Having cognitive impairment according to patient's medical documents; referral to other medical centers during the study; Inability to read short messages (inability to read and write, visual impairment); Having systolic heart failure.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Medication adherence. Timepoint: Before the beginning of intervention and soon as the end of intervention at the end of the sixth month. Method of measurement: Morisky medication adherence questionaire(MMAS-8).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Atefeh Allahbakhshian

Tabriz University of Medical Sciences

allahbakhshiana@tbzmed.ac.ir+98 41 3479 6770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026